Showing results (111-120 of 150) with videos related to
Sort By:
Pageof 15
Archives of Internal Medicine|October 1, 1989
The impact of the prospective payment system on the treatment of hip fractures in the elderlyR M Palmer, R M Saywell, T W Zollinger, et al.Frontiers in Veterinary Science|October 24, 2022
Improving farm-level antimicrobial stewardship benchmarks by reporting antimicrobial use within the context of both the magnitude of disease pressure and the outcome of therapyNora F D Schrag, Sandra M Godden, Randall S Singer, et al.Journal of Structural Biology|January 8, 1999
Identification and crystallization of a protease-resistant core of calnexin that retains biological activityM Hahn, S Borisova, J D Schrag, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 16, 2014
Phase I trial of olaparib in combination with cisplatin for the treatment of patients with advanced breast, ovarian and other solid tumorsJ Balmaña, N M Tung, S J Isakoff, et al.Nature Genetics|December 1, 1994
Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancerL H Castilla, F J Couch, M R Erdos, et al.American Journal of Human Genetics|January 1, 1995
An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families. Breast Cancer Linkage ConsortiumS A Narod, D Ford, P Devilee, et al.Oncogene|August 26, 1998
Germline mutations in PTEN are an infrequent cause of genetic predisposition to breast cancerM G FitzGerald, D J Marsh, D Wahrer, et al.Annals of Internal Medicine|December 1, 1980
Waldenström's macroglobulinemia and autoimmune disease in a familyW A Blattner, J E Garber, D L Mann, et al.Journal of Surgical Oncology|June 26, 2010
Meeting the 12 lymph node (LN) benchmark in colon cancerA Rajput, D Romanus, M R Weiser, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2000
Docetaxel administered on a weekly basis for metastatic breast cancerH J Burstein, J Manola, J Younger, et al.Pageof 15